Jessica N. Abraham | Designer. Writer. Publicist.

19+ Years of Expertise in Digital Marketing, Social Branding and Public Relations.

  • Home
  • Contact
  • About
  • Home
  • Contact
  • About

No Widgets found in the Sidebar Alt!

  • Cell Transplant, Eye Transplant, Cellular Regeneration, Regeneration Therapy,
    Health,  Benzinga,  Biotechnology,  Business,  Finance,  Regenerative Medicine

    Lineage, Pioneering a New Branch of Medicine — OpRegen Continues to Show Promising Results in Dry AMD with Geographic Atrophy

    October 21, 2021 /

    Previously Published on Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Lineage Cell Therapeutics Inc. (AMEX: LCTX) recently provided an update on its lead program OpRegen®, a cell replacement therapy for dry age-related macular degeneration (AMD) with geographic atrophy (GA).  Lineage is pioneering a new branch of medicine, which is manufacturing differentiated cell types and transplanting those cells into the body, to restore or improve function which has been lost due to injury or disease.  The data from an ongoing Phase 1/2a clinical study continued to demonstrate that a single administration of OpRegen, an investigational cell therapy consisting of…

    read more
    Jessica N. Abraham Comments Off on Lineage, Pioneering a New Branch of Medicine — OpRegen Continues to Show Promising Results in Dry AMD with Geographic Atrophy

    You May Also Like

    Statera Pharmaceuticals treatment for Covid-19 Long-Haulers

    Groundbreaking Studies to Be Conducted on the Effectiveness of Short and Long-term COVID-19 Therapies Inhibiting the Progression of SARS-CoV-2

    October 28, 2021
    IotaComm, IoT, Internet of Things, Smart Buildings, Smart Cities, Finance, Benzinga, Connected, Building Intelligence, Building Analytics,

    This Tool Uses IoT to Turn Old Buildings into Data Powerhouses, Improves Air Quality and Keeps Staff Healthy

    August 27, 2021
    Statera Biopharmaceuticals, Groundbreaking Biomedicine Treatment

    Statera BioPharma: The Ticker Formerly Known as CBLI

    September 7, 2021
  • Business
  • Technology
  • Career Development
  • Education
  • Entertainment
  • Fashion
  • Relationships
  • Tips
  • Travel
Ashe Theme by WP Royal.